Skip to search formSkip to main contentSkip to account menu

palivizumab

Known as: PALI, Palivizumab [Chemical/Ingredient], anti-RSV 
A humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylactic application in… 
National Institutes of Health

Related topics

Related topics

14 relations
1 ML palivizumab 100 MG/ML Injection1 ML palivizumab 100 MG/ML Injection [Synagis]Congenital Heart DefectsDrug Allergy

Broader (1)

Antiviral Agents

Narrower (2)

MEDI 493Synagis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention.
Highly Cited
2007
Highly Cited
2007
Risperidone and Paliperidone Inhibit P-Glycoprotein Activity In Vitro
Risperidone (RSP) and its major active metabolite, 9-hydroxy-risperidone (paliperidone, PALI), are substrates of the drug… 
Review
2005
Review
2005
Palivizumab for preterm infants. Is it worth it?
Respiratory syncytial virus infection is an important cause of morbidity. Although palivizumab prophylaxis is widely used, it is… 
2004
2004
Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002
Background. There are few independent, population-based reports that estimate the risk of hospitalization of respiratory… 
2003
2003
Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody.
Review
2003
Review
2003
Current strategies in the prevention of respiratory syncytial virus disease.
2003
2003
Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease
New data are emerging on the use of palivizumab as prophylaxis against infection with the respiratory syncytial virus in infants… 
2002
2002
Crystal structure of conserved hypothetical protein Aq1575 from Aquifex aeolicus
The crystal structure of a conserved hypothetical protein, Aq1575, from Aquifex aeolicus has been determined by using x-ray… 
1997
1997
Expression of EcR and USP in Escherichia coli: purification and functional studies.
The functional ecdysteroid receptor complex consists of a nuclear receptor heterodimer of ecdysteroid receptor (EcR) and… 
Review
1972
Review
1972
The PALI and the SLIC systems.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)